Sunshine Biopharma Inc. Quarterly Cost of Revenue in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Sunshine Biopharma Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2017 to Q3 2024.
  • Sunshine Biopharma Inc. Cost of Revenue for the quarter ending September 30, 2024 was $5.57M, a 40.4% increase year-over-year.
  • Sunshine Biopharma Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $7.08M, a 45.9% decline year-over-year.
  • Sunshine Biopharma Inc. annual Cost of Revenue for 2023 was $15.8K, a 99.4% decline from 2022.
  • Sunshine Biopharma Inc. annual Cost of Revenue for 2022 was $2.65M, a 2148% increase from 2021.
  • Sunshine Biopharma Inc. annual Cost of Revenue for 2021 was $118K, a 356% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $7.08M $5.57M +$1.6M +40.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $5.48M $6.95M +$3.34M +92.5% Apr 1, 2024 Jun 30, 2024 10-Q/A 2024-08-20
Q1 2024 $2.14M $5.19M +$2.12M +69.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 $15.8K -$10.6M -$13.1M -534% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $13.1M $3.97M +$3.9M +5931% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $9.19M $3.61M +$3.53M +4731% Apr 1, 2023 Jun 30, 2023 10-Q/A 2024-08-20
Q1 2023 $5.66M $3.07M +$3.01M +5023% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 $2.65M $2.45M +$2.39M +3895% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $262K $65.8K +$46.3K +237% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $215K $74.7K +$56.2K +303% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $159K $59.8K +$41.3K +223% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $118K $61.3K +$50.8K +486% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-04
Q3 2021 $67K $19.5K +$13.2K +208% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $53.8K $18.5K +$13.4K +259% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $40.5K $18.5K +$14.6K +377% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $25.8K $10.5K +$6.28K +150% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-21
Q3 2020 $19.6K $6.34K +$1.05K +19.8% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $18.5K $5.16K +$3.7K +253% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $14.8K $3.88K +$3.77K +3367% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $11.1K $4.19K +$105K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$94K $5.29K +$5.29K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$99.2K $1.46K +$1.46K Apr 1, 2019 Jun 30, 2019 10-Q/A 2020-08-31
Q1 2019 -$101K $112 -$101K -99.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18
Q4 2018 $0 -$101K Oct 1, 2018 Dec 31, 2018 10-K 2020-05-01
Q3 2018 $0 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 $0 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-15
Q1 2018 $101K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q3 2017 $0 Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 $0 Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.